Literature DB >> 28226323

Immune Complex Membranoproliferative Glomerulonephritis Associated with Transjugular Intrahepatic Portosystemic Shunts in Alcoholic Cirrhosis: Two Case Reports.

Julio Hernández-Jaras1, Jordi Espí-Reig, Rafael Alis, Ana-Maria García-Martínez, Diego Rodríguez-Ortega, Lourdes Roca-Argente, Jose-Luis Moll-Guillen.   

Abstract

OBJECTIVE: To report on 2 patients with alcoholic cirrhosis who were treated with transjugular intrahepatic portosystemic shunt (TIPS) placement. CLINICAL PRESENTATION AND INTERVENTION: The 2 patients had a history of alcoholic cirrhosis, and TIPS surgery was performed on them. In both cases, 4 months after TIPS placement, proteinuria was observed along with histological alterations characteristic of immune complex membranoproliferative glomerulonephritis (MPGN).
CONCLUSION: The TIPS in one patient was successful without immediate complications, while the other patient was referred for a combined liver-kidney transplant. In both cases, immune complex MPGN might have developed after TIPS placement probably due to a reduced immune complex clearance.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Hepatic cirrhosis; Membranoproliferative glomerulonephritis; Membranous glomerulonephritis; Portosystemic shunt; Transjugular intrahepatic portosystemic shunt

Mesh:

Substances:

Year:  2017        PMID: 28226323      PMCID: PMC5588412          DOI: 10.1159/000464365

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  8 in total

1.  'Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt.

Authors:  A D Smet; D Kuypers; P Evenepoel; B Maes; T Messiaen; B Van Damme; Y Vanrenterghem
Journal:  Nephrol Dial Transplant       Date:  2001-11       Impact factor: 5.992

Review 2.  Membranoproliferative glomerulonephritis--a new look at an old entity.

Authors:  Sanjeev Sethi; Fernando C Fervenza
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

Review 3.  The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.

Authors:  Luis Colombato
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

4.  Membranoproliferative glomerulonephritis in congenital portosystemic shunt without liver cirrhosis.

Authors:  S Karashima; S Hattori; H Nakazato; H Awata; S Seguchi; S Ikeda; Y Sera; F Endo
Journal:  Clin Nephrol       Date:  2000-03       Impact factor: 0.975

5.  Membranoproliferative glomerulonephritis induced by portosystemic shunt surgery for non-cirrhotic portal hypertension.

Authors:  J Soma; T Saito; H Sato; T Ootaka; K Abe
Journal:  Clin Nephrol       Date:  1997-11       Impact factor: 0.975

Review 6.  Acute Kidney Injury in Cirrhosis.

Authors:  Constantine J Karvellas; Francois Durand; Mitra K Nadim
Journal:  Crit Care Clin       Date:  2015-08-05       Impact factor: 3.598

7.  Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells.

Authors:  I Kosugi; H Muro; H Shirasawa; I Ito
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083

8.  Remission of membranoproliferative glomerulonephritis associated with a noncirrhotic portosystemic shunt after percutaneous transhepatic portal vein embolization.

Authors:  Nobuhiko Okamoto; Sawako Fukazawa; Masafumi Shimamoto; Rie Yamamoto; Yuichiro Fukazawa
Journal:  NDT Plus       Date:  2009-02-16
  8 in total
  1 in total

Review 1.  Presentation of Congenital Portosystemic Shunts in Children.

Authors:  Atessa Bahadori; Beatrice Kuhlmann; Dominique Debray; Stephanie Franchi-Abella; Julie Wacker; Maurice Beghetti; Barbara E Wildhaber; Valérie Anne McLin
Journal:  Children (Basel)       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.